Organization · Private Equity
Evolution Venture Partners
Evolution Venture Partners is a healthcare investment banking boutique that specializes in capital formation, mergers and acquisitions, and strategic advisory within the life sciences and health sectors. They support both public and private companies during critical phases of their corporate development.
Overview
What Evolution Venture Partners does
What Evolution Venture Partners is
Evolution Venture Partners is a healthcare investment banking boutique that specializes in capital formation, mergers and acquisitions, and strategic advisory within the life sciences and health sectors. They support both public and private companies during critical phases of their corporate development.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Structured capabilities
- Funder
- Last reviewed
- March 5, 2026
Official channels
Find Evolution Venture Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Evolution Venture Partners as a funder
Investment thesis
EVP focuses on capital formation, mergers and acquisitions, and strategic advisory within the healthcare sector. They assist both public and private companies in raising capital and structuring transactions.
Focus narrative
EVP invests in and provides services related to capital formation, mergers and acquisitions (M&A), strategic advisory, and partnering activities within the healthcare sector. They work with both public and private companies, assisting in raising capital, structuring transactions, and facilitating partnerships. Their approach includes reaching out to institutional investors and leveraging a network of relationships with healthcare-focused investment funds.
Focus and fit
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded notable exits
- Smart Immune, Alethia Biopharmaceuticals, and Gotham Therapeutics
Portfolio context
Notable transactions facilitated by EVP include: - Smart Immune: Acquired by Meira GTX (July 2025) - KisoJi Biotechnology: $41,000,000 private placement (October 2024) - Alethia Biopharmaceuticals: Acquired by NantBio (November 2023) - GRI Bio: Merged with Vallon Pharmaceuticals (April 2023); also involved in multiple financing rounds totaling $21,000,000 (December 2022 and April 2023) - Palisade Bio: $5,200,000 private placement (April 2023) - Gotham Therapeutics: Acquired by 858 Therapeutics (June 2020) - Precision Biologics: $50,000,000 equity investment (October 2015)
Common questions
What to know about Evolution Venture Partners
Upseed classifies Evolution Venture Partners under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.